FORM 8-K/A-2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 1998 MEDTOX SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 1-11394 95-3863205 (Commission File Number) (IRS Employer Identification No.) 402 West County Road D St. Paul, Minnesota 55112 (Address of principal executive offices) (Zip Code) (612) 636-7466 (Registrant's telephone number, including area code) Item 4. Change In Independent Accountants Effective May 27, 1998, the Registrant terminated Ernst & Young LLP as its independent accounting firm. Exhibit 16 is the response of Ernst & Young LLP to the disclosures made by the Registrant on Form 8-K/A dated June 3, 1998. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDTOX Scientific, Inc. Date: June 23, 1998 By: /s/ Peter J. Heath Name: Peter J. Heath Title: Vice President of Finance and Chief Financial Officer